Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis

por Carrothers, Timothy J., Chittenden, Jason T., Critchley, Ian
Publicado 2019

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients

por Carrothers, Timothy J, Lagraauw, H Maxime, Lindbom, Lars, Riccobene, Todd
Publicado 2020

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients

por Carrothers, Timothy J., Lagraauw, H. Maxime, Lindbom, Lars, Riccobene, Todd A.
Publicado 2022

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

por Esposito, Susanna, Carrothers, Timothy J., Riccobene, Todd, Stone, Gregory G., Kantecki, Michal
Publicado 2021

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

por Esposito, Susanna, Carrothers, Timothy J., Riccobene, Todd, Stone, Gregory G., Kantecki, Michal
Publicado 2021

Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5‐Minute Infusion

por Riccobene, Todd A., Carrothers, Timothy J., Knebel, William, Raber, Susan, Chan, Phylinda L.S.
Publicado 2021

The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections

por Giorgobiani, Manana, Burroughs, Margaret H., Antadze, Tinatin, Carrothers, Timothy J., Riccobene, Todd A., Patel, Rinal, Lin, Tao, Stefanova, Penka
Publicado 2022

Exposure–response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters

por Garg, Amit, Li, Jing, Clark, Emma, Knott, Adam, Carrothers, Timothy J., Marier, Jean-François, Cortés, Javier, Brewster, Michael, Visich, Jennifer, Lum, Bert
Publicado 2013

Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older

por Franzese, Richard C., McFadyen, Lynn, Watson, Kenny J., Riccobene, Todd, Carrothers, Timothy J., Vourvahis, Manoli, Chan, Phylinda L.S., Raber, Susan, Bradley, John S., Lovern, Mark
Publicado 2021

Asenapine pharmacokinetics and tolerability in a pediatric population

por Dogterom, Peter, Riesenberg, Robert, de Greef, Rik, Dennie, Justin, Johnson, Martin, Pilla Reddy, Venkatesh, Miltenburg, André MM, Findling, Robert L, Jakate, Abhijeet, Carrothers, Timothy J, Troyer, Matthew D
Publicado 2018

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups

por Li, Jianguo, Lovern, Mark, Green, Michelle L., Chiu, Joannellyn, Zhou, Diansong, Comisar, Craig, Xiong, Yuan, Hing, Jeremy, MacPherson, Merran, Wright, James G., Riccobene, Todd, Carrothers, Timothy J., Das, Shampa
Publicado 2018